Can I get alcohol medication online?

Yes — and the more useful question is what a legitimate online program actually does before it hands you a prescription, and how to tell a careful one from a pill mill.

You have probably searched some version of "can I get something for drinking without sitting in a waiting room," half-expecting the answer to be no, or to be a catch. It isn't. The three medications the FDA has approved for alcohol use disorder — naltrexone, acamprosate, and disulfiram — can all be prescribed through telehealth, where a licensed clinician reviews your history by video, phone, or secure messaging and, if it's a fit, sends the prescription to a pharmacy that ships to you (NIAAA's telehealth overview). The part worth slowing down for isn't whether it's possible. It's what should happen in between.

What actually happens in an online visit?

A real evaluation, not a checkout page. Most programs start with a health questionnaire, then a consultation with a clinician licensed in your state. They ask about your drinking, your goals, other medications you take, and your medical history — and only then decide whether a prescription makes sense. If a service lets you buy a medication for alcohol with no review of any of that, treat it as a red flag rather than a convenience.

What comes after the first visit varies. Some programs bundle in coaching or check-in messaging; others are mostly the medical visit plus refills. Neither is automatically better. What matters is that a clinician stays in the loop for follow-up, because these medications work best alongside some kind of support rather than on their own — that's how the professional guidance frames it, too (American Academy of Family Physicians).

Do I have to be a "severe" case to qualify?

No. Nothing about telehealth prescribing requires you to have hit a rock bottom or to accept a label you don't feel fits. The clinical question is narrower and more practical: is a given medication safe and reasonable for your situation? Plenty of people asking are still holding down a job and their responsibilities and simply notice that drinking is starting to cost them — sleep, mornings, follow-through, the way they talk to people they love.

If that's you, it counts. You do not need to wait until things are worse to ask a medical question about it.

Which medication would they even consider?

That depends on you, and it's genuinely a conversation, not a menu you pick from. The three approved options do different jobs. In plain terms: one (disulfiram) makes you feel sick if you drink, so it works like a tripwire; one (naltrexone) turns down the pleasant lift a drink gives you, so drinking feels less worth it; and one (acamprosate) leaves that reward alone and instead helps steady the restless, off-balance feeling that can linger for months after you stop. Researchers have compared them head to head — the U.S. Agency for Healthcare Research and Quality found that oral naltrexone and acamprosate each have moderate-strength evidence for helping people avoid a return to drinking (AHRQ systematic review).

That's useful background, not a self-diagnosis. Which one — if any — fits your goals and your health is exactly what the clinician visit is for.

What will they check before prescribing?

The screening is about safety, and a few things carry real weight:

• Opioid medications. This is the big one for naltrexone. If you take opioid pain medication or medication for opioid use, naltrexone can be genuinely unsafe, so a careful clinician asks about it directly (DailyMed label).
• Liver and kidney history. How your body clears a medication shapes which one is reasonable, which is why these come up.
• Your drinking pattern and any withdrawal history. Not to judge it — to gauge whether stopping is something you can do safely from home, or whether you need in-person care first.
• Pregnancy, other medications, and allergies. Standard, but they matter here too.

A program that skips this is not protecting your privacy. It's cutting a corner that exists for your safety.

Is it actually private?

Telehealth spares you the local-clinic waiting room, and that's a real reason people choose it. Your medical records are protected under HIPAA, the federal law that keeps your health information from being shared without your say-so (HHS overview), and records specifically tied to substance use carry an extra layer of federal confidentiality protection on top of that (SAMHSA).

Privacy isn't the whole story, though. A service can be discreet and still be thin on the things that actually matter — clinical oversight, a way to reach someone about side effects, real follow-up. Discretion is a feature; it isn't a substitute for care.

Questions to bring before you sign up

You are allowed to interview the service, not just the other way around. Before you commit, ask:

• Are your clinicians licensed in my state?
• What happens if you decide a medication isn't safe for me — do I still get a real recommendation, or just a refund?
• How do you screen for withdrawal risk and opioid use?
• What follow-up is included after the first prescription?
• How do prescription shipping, billing, cancellation, and data privacy work — including what shows up on a statement and whether my health data is used for marketing?

None of that is overthinking it. If you've been quietly managing a job or a family while worrying about your drinking, getting clear answers is what makes the first step feel smaller.

When online isn't the right first stop

Most people can start this conversation from home. But if stopping or cutting back on your own has ever brought on shaking, sweating, a racing heart, confusion, or a seizure, that's not a telehealth question — alcohol withdrawal can turn dangerous fast, and that belongs with in-person care. If any of that is happening now, call 911 or go to an emergency room; to plan a safe stop before it gets to that point, the SAMHSA National Helpline (1-800-662-HELP) can point you to nearby options, and it's worth reading how alcohol withdrawal works first.

Why so few people ever get offered this

Here's the quiet backdrop to all of it. In 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder — about 9.7% of that age group — yet only about 2.1 million of them, roughly 7.6%, received any alcohol treatment at all (NIAAA). The number offered a medication is smaller still.

Read that as an access problem, not a verdict on the medicines. For most people, the appointment where a medication could even come up simply never happens — the clinician who might raise it is never in the room. Clero can move that first medication question into a telehealth clinician review; whether an option such as naltrexone fits is still individualized.

This is general education, not medical advice or a prescription — which medication, if any, is right for you is a call to make with a licensed clinician who can see your whole health history.

Coming soon

Want the private naltrexone update?

Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.

Get the naltrexone updateNot a prescription request, not medical advice, and not available for treatment today.